• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Seventeen novel SERPINC1 variants causing hereditary antithrombin deficiency in a Czech population.

作者信息

Provazníková Dana, Matýšková Miloslava, Čápová Irena, Grančarová Dagmar, Drbohlavová Eva, Šlechtová Marie, Hrachovinová Ingrid

机构信息

NRL for Disorders in Hemostasis, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.

Clinical Hematology Department, University Hospital Brno, Brno, Czech Republic.

出版信息

Thromb Res. 2020 May;189:39-41. doi: 10.1016/j.thromres.2020.02.025. Epub 2020 Mar 2.

DOI:10.1016/j.thromres.2020.02.025
PMID:32151802
Abstract
摘要

相似文献

1
Seventeen novel SERPINC1 variants causing hereditary antithrombin deficiency in a Czech population.在捷克人群中发现17种导致遗传性抗凝血酶缺乏症的新型SERPINC1变体。
Thromb Res. 2020 May;189:39-41. doi: 10.1016/j.thromres.2020.02.025. Epub 2020 Mar 2.
2
Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency.新型丝氨酸蛋白酶抑制剂 C1（SERPINC1）错义突变（Cys462Tyr）导致 279Cys-462Cys 二硫键断裂，引起Ⅰ型遗传性抗凝血酶缺乏症。
Clin Biochem. 2020 Nov;85:38-42. doi: 10.1016/j.clinbiochem.2020.07.004. Epub 2020 Aug 1.
3
A novel mutation p.Met1Val in SERPINC1 gene causes hereditary antithrombin deficiency in a Chinese family with thrombotic disease.SERPINC1基因中的一种新型突变p.Met1Val导致一个患有血栓性疾病的中国家庭出现遗传性抗凝血酶缺乏症。
Thromb Res. 2023 Dec;232:104-107. doi: 10.1016/j.thromres.2023.11.002. Epub 2023 Nov 11.
4
Phenotypic and Genotypic Analysis of a Hereditary Antithrombin Deficiency Pedigree Due to a Novel SERPINC1 Mutation (p.Met281Thr).由于新型 SERPINC1 突变（p.Met281Thr）导致遗传性抗凝血酶缺陷家系的表型和基因型分析。
Hamostaseologie. 2020 Dec;40(5):687-690. doi: 10.1055/a-1145-4224. Epub 2020 May 25.
5
New genetic variant in the SERPINC1 gene: hereditary Antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling.SERPINC1 基因新的遗传变异：遗传性抗凝血酶缺陷症病例报告、家族性血栓形成及遗传咨询的考虑。
BMC Med Genet. 2020 Apr 6;21(1):73. doi: 10.1186/s12881-020-01001-5.
6
Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.凝血酶原酶抑制物 1 基因突变类型和抗凝血酶缺乏症亚型对遗传性抗凝血酶缺乏症血栓表型的影响。
Thromb Haemost. 2014 Feb;111(2):249-57. doi: 10.1160/TH13-05-0402. Epub 2013 Nov 7.
7
A heparin binding site Arg79Cys missense mutation in the SERPINC1 gene in a Korean patient with hereditary antithrombin deficiency.一名患有遗传性抗凝血酶缺乏症的韩国患者的SERPINC1基因中存在肝素结合位点Arg79Cys错义突变。
Ann Clin Lab Sci. 2011 Fall;41(1):89-92.
8
SERPINC1 gene mutations in antithrombin deficiency.抗凝血酶缺乏症中的SERPINC1基因突变。
Br J Haematol. 2017 Jul;178(2):279-285. doi: 10.1111/bjh.14658. Epub 2017 Mar 20.
9
Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.日本抗凝血酶缺陷症患者 SERPINC1 突变的分子基础。
Thromb Res. 2019 Jun;178:159-170. doi: 10.1016/j.thromres.2019.04.004. Epub 2019 Apr 11.
10
Molecular basis of antithrombin deficiency.抗凝血酶缺陷的分子基础。
Thromb Haemost. 2011 Apr;105(4):635-46. doi: 10.1160/TH10-08-0538. Epub 2011 Jan 25.

引用本文的文献

1
Heterozygosity for the Budapest 3 mutation in SERPINC1 in a family with thrombophilia and structural anomalies of the inferior vena cava.一个患有易栓症和下腔静脉结构异常的家族中，SERPINC1基因布达佩斯3突变的杂合性。
Thromb J. 2024 Aug 12;22(1):75. doi: 10.1186/s12959-024-00644-1.
2
Proteomics analysis of plasm exosomes in early pregnancy among normal pregnant women and those with antiphospholipid syndrome.正常孕妇和抗磷脂综合征孕妇孕早期血浆外泌体的蛋白质组学分析。
Heliyon. 2024 Apr 12;10(8):e29224. doi: 10.1016/j.heliyon.2024.e29224. eCollection 2024 Apr 30.
3
Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation.
低分子肝素治疗抗凝血酶缺陷合并杂合子 HBS II 突变的孕妇后凝血酶生成减少。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231197174. doi: 10.1177/10760296231197174.
4
Functional, biochemical, molecular and clinical characterization of antithrombin c.1157T>C (p.Ile386Thr), a recurrent Polish variant with a founder effect.抗凝血酶c.1157T>C（p.Ile386Thr）的功能、生化、分子及临床特征，一种具有奠基者效应的波兰复发性变异体
Haematologica. 2023 Oct 1;108(10):2803-2807. doi: 10.3324/haematol.2022.282459.
5
Favourable outcome of multisystem venous thrombosis associated with novel SERPINC1 mutation after treated with dabigatran: a case report with 7-year follow-up.达比加群治疗后与新型SERPINC1突变相关的多系统静脉血栓形成的良好结局：一项7年随访的病例报告
Thromb J. 2022 Dec 28;20(1):81. doi: 10.1186/s12959-022-00446-3.
6
Nanozyme and Stimulated Fluorescent Cu-Based Metal-Organic Frameworks (Cu-MOFs) Functionalized with Engineered Aptamers as a Molecular Recognition Element for Thrombin Detection in the Plasma of COVID-19 Patients.纳米酶与经工程适体功能化的刺激荧光铜基金属有机框架（Cu-MOFs）作为新冠患者血浆中凝血酶检测的分子识别元件
ACS Omega. 2022 Oct 5;7(41):36804-36810. doi: 10.1021/acsomega.2c05232. eCollection 2022 Oct 18.
7
Detection of Unknown and Rare Pathogenic Variants in Antithrombin, Protein C and Protein S Deficiency Using High-Throughput Targeted Sequencing.使用高通量靶向测序检测抗凝血酶、蛋白C和蛋白S缺乏症中的未知和罕见致病变异体。
Diagnostics (Basel). 2022 Apr 23;12(5):1060. doi: 10.3390/diagnostics12051060.
8
Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients.新冠肺炎住院患者血栓生成参数的预后价值。
Sci Rep. 2021 Apr 8;11(1):7792. doi: 10.1038/s41598-021-85906-y.